(Q36403643)

14 August 2017

1 reference

title

First-episode psychosis, early intervention, and outcome: what have we learned? (English)

1 reference

14 August 2017

1 reference

Ashok K Malla

1

1 reference

14 August 2017

Ross M G Norman

series ordinal

2

1 reference

14 August 2017

Ridha Joober

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Canadian Journal of Psychiatry

14 August 2017

published in

1 reference

14 August 2017

volume

50

1 reference

14 August 2017

issue

14

1 reference

14 August 2017

page(s)

881-891

1 reference

Measures of quality of life among persons with severe and persistent mental disorders

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

One hundred years of schizophrenia: a meta-analysis of the outcome literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Psychological treatments in schizophrenia: II. Meta-analyses of randomized controlled trials of social skills training and cognitive remediation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II: Postnegative distinction and childhood predictors of adult outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

The neurodevelopmental basis of sex differences in schizophrenia1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Sex and Schizophrenia: Effects of Diagnostic Stringency, and Associations with Premorbid Variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Premorbid adjustment in first episode schizophrenia and schizoaffective disorders: a comparison of social and academic domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Treating psychosis: is there more to early intervention than intervening early?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

The dimensional structure of first episode psychosis: an exploratory factor analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

The Natural Course of Schizophrenia: A Review of First-admission Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Recovery from psychotic illness: a 15- and 25-year international follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Involuntary first admission of patients with schizophrenia as a predictor of future admissions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Pathways to care of first-admitted subjects with psychosis in South-Western France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Understanding delay in treatment for first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Duration of untreated psychosis: impact on 2-year outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Is early intervention for psychosis a waste of valuable resources?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Value of early intervention in psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

EPPIC: an evolving system of early detection and optimal management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Early intervention and a five year follow up in young adults with a short duration of untreated psychosis: ethical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Status of patients with first-episode psychosis after one year of phase-specific community-oriented treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

First-episode psychosis: psychopathology, quality of life, and functional outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

EEG abnormalities and outcome in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

EEG abnormalities and two year outcome in first episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Duration of untreated psychosis: a critical examination of the concept and its importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Early detection and assertive community treatment of young psychotics: the Opus Study Rationale and design of the trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

What are the functional consequences of neurocognitive deficits in schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Symptom Outcome 1 Year after Admission to an Early Psychosis Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Does treatment delay in first-episode psychosis really matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Course of patients diagnosed as having schizophrenia during first episode occurring under age 18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Adult outcome of social function in adolescent-onset schizophrenia and affective psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Intervention research in psychosis: issues related to the assessment of quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Subjective and external assessments of quality of life in schizophrenia: relationship to insight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Determinants of quality of life in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Impact of phase-specific treatment of first episode of psychosis on Wisconsin Quality of Life Index (client version).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

A new patient focused index for measuring quality of life in persons with severe and persistent mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Early detection and intervention in first-episode schizophrenia: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Neuroleptics and the Natural Course of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Determinants of quality of life at first presentation with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Earlier detection and intervention in schizophrenia: unsolved questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Early detection strategies for untreated first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Removing Barriers to Treatment of First-Episode Psychotic Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

A community intervention for early identification of first episode psychosis: impact on duration of untreated psychosis (DUP) and patient characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Reducing the duration of untreated first-episode psychosis: effects on clinical presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

The prodromal phase of first-episode psychosis: past and current conceptualizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

The initial prodrome in psychosis: descriptive and qualitative aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370505001402

10.1177/070674370505001402

21 January 2018

Identifiers

DOI

0 references

1 reference